Intech Investment Management LLC Acquires Shares of 28,539 ASP Isotopes Inc. (NASDAQ:ASPI)

Intech Investment Management LLC bought a new position in shares of ASP Isotopes Inc. (NASDAQ:ASPI) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 28,539 shares of the company’s stock, valued at approximately $129,000.

A number of other hedge funds also recently modified their holdings of ASPI. Charles Schwab Investment Management Inc. grew its stake in ASP Isotopes by 16.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 120,278 shares of the company’s stock worth $334,000 after buying an additional 17,159 shares in the last quarter. The Manufacturers Life Insurance Company bought a new stake in shares of ASP Isotopes during the 3rd quarter worth approximately $52,000. MetLife Investment Management LLC acquired a new stake in shares of ASP Isotopes during the 3rd quarter worth approximately $88,000. Walleye Capital LLC bought a new position in ASP Isotopes in the third quarter valued at approximately $536,000. Finally, Verition Fund Management LLC acquired a new position in ASP Isotopes during the third quarter valued at approximately $101,000. Institutional investors own 16.80% of the company’s stock.

ASP Isotopes Trading Up 12.9 %

Shares of ASPI stock opened at $4.73 on Friday. ASP Isotopes Inc. has a fifty-two week low of $1.86 and a fifty-two week high of $9.33. The stock’s fifty day moving average price is $5.04 and its two-hundred day moving average price is $4.89. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55. The company has a market cap of $337.67 million, a PE ratio of -7.75 and a beta of 3.66.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.